In a similar study, we showed that this new recombinant strain can attenuate the severity of intestinal inflammation in acute TNBS-induced colitis by increasing the levels of the anti-inflammatory cytokine IL-10 and immunoglobulin sIgA20. The gene discussed is IL10; the disease is inflammation.